The relevance of IL-1R1 in MS is supported by previous results reporting that IL-1R1-deficient mouse T cells developed a delayed and less severe EAE, and a lower percentage of IL-17 producing cells in the inflamed CNS compared to wild type mice15. The gene discussed is IL17A; the disease is myeloid sarcoma.